Clinical Trials For The Retina Specialist

The Importance of Adverse Event Reporting

Aron Shapiro

One Year After Aflibercept: Where Are We With Therapeutic Approaches for Retinal Vascular Diseases?

Aron Shapiro with David Boyer, MD, and Quan Dong Nguyen, MD, MSC

Adopting and Adapting Imaging Tools for Clinical Use

Aron Shapiro and Ashley Lafond

Clinical Trials from the Statistician's Side: Reducing Variability

Aron Shapiro and Dale Usner, PhD

Recruiting for Invasive Clinical Trials

Aron Shapiro and Ashley Lafond